Abstract | BACKGROUND: OBJECTIVE: METHODS: RESULTS: A total of 117 patients were included in the present analyses. Of those, 26 (22.2%), 51 (43.6%) and 40 (34.2%) patients had compensated or decompensated liver cirrhosis, and ACLF. Plasma levels of ARA and DHA were similar in patients with compensated cirrhosis, decompensated cirrhosis, and ACLF. Furthermore, no significant association between plasma ARA or DHA and C-reactive protein or peripheral blood leukocytes were observed (P>0.05). CONCLUSION:
|
Authors | Katharina Maria Schwarzkopf, Alexander Queck, Dominique Thomas, Carlo Angioni, Chengcong Cai, Ylva Freygang, Sabrina Rüschenbaum, Gerd Geisslinger, Stefan Zeuzem, Christoph Welsch, Christian Markus Lange |
Journal | PloS one
(PLoS One)
Vol. 14
Issue 1
Pg. e0211537
( 2019)
ISSN: 1932-6203 [Electronic] United States |
PMID | 30703151
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Fatty Acids, Omega-3
- Fatty Acids, Omega-6
|
Topics |
- Acute-On-Chronic Liver Failure
(blood, diagnosis, etiology)
- Biomarkers
(blood)
- Fatty Acids, Omega-3
(blood)
- Fatty Acids, Omega-6
(blood)
- Female
- Humans
- Inflammation
(blood, diagnosis, etiology)
- Liver Cirrhosis
(complications)
- Male
- Middle Aged
- Prognosis
- Prospective Studies
|